EXTRACELLULAR-MATRIX OF CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS CONTAINS FUNCTIONALLY ACTIVE TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR

  • 1 September 1987
    • journal article
    • research article
    • Vol. 70  (3) , 721-728
Abstract
The extracellular matrix (ECM) of cultured bovine aortic endothelial cells (BAEs) was analyzed by immunoblotting and reverse fibrin autography and shown to contain type 1 plasminogen activator inhibitor (PAI-1). Most PAI-1 in the ECM formed complexes with exogenously added tissue-type plasminogen activator (tPA), demonstrating that this PAI 1 was functionally active. The resulting tPA/PAI-1 complexes were recovered in the reaction solution, indicating that the PAI-1 in such complexes no longer bound to ECM. The PAI-1 could not be removed by incubating ECM in high salt (2 mol/L NaCl), sugars (1 mol/L galactose, 1 mol/L mannose), glycosaminoglycans (10 mmol/L heparin, 10 mmol/L dermatan sulfate), or .epsilon.-aminocaproic acid (0.1 mol/L). However, PAI-1 could be extracted from ECM by treatment with either arginine (0.5 mol/L) or potassium thiocyanate (2 mol/L), or by incubation under acidic conditions (pH 2.5). ECM depleted of PAI-1 by acid extraction was able to bind both the active and latent forms of PAI-1. In this instance, most of the bound PAI-1 did not form complexes with tPA, indicating that the latent form was not activated as a consequence of binding to ECM. Although the PAI-1 activity in conditioned medium decayed with a half-life (t1/2) of < 3 hours, the t1/2 of ECM-associated PAI-1 was > 24 hours. These data suggest that PA1-1 is produced by cultured BAEs in an active form and is then either released into the medium whre it is rapidly inactivated or into the subendothelium where it binds to ECM. The specific binding of PAl-1 to ECM protects it from this inactivation.